Rating History for Navidea Biopharmaceuticals (NAVB) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for NAVB
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/6/2013 N/A New Coverage Underweight
(N/A)		 1.50
(N/A)		 3.15
(0.00)		 -100% Details